Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pawelec

Showing results (51-60 of 222) with videos related to

Pageof 23
Sort By:
Cancer Immunology, Immunotherapy : CII|August 4, 1999
Prerequisites for the immunotherapy of cancerG Pawelec, A Engel, M Adibzadeh
Cancer Chemotherapy and Pharmacology|January 1, 1995
In vitro effect of r-verapamil on acute myelogenous leukemia blast cells: studies of cytokine secretion and cytokine-dependent blast proliferationO Bruserud, I Nesthus, G Pawelec
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 5, 2002
Generation of chronic myelogenous leukemia-specific T cells in cytokine-modified autologous mixed lymphocyte/tumor cell culturesL Müller, C Provenzani, G Pawelec
Trends in Immunology|August 9, 2001
MHC class II-restricted tumor antigens and CD4+ T cells play a role in hematological malignancies as well as solid tumorsG Pawelec, L Müller, W Wagner
International Journal of Immunopharmacology|January 1, 1991
The anti-fungal agent itraconazole exerts immunosuppressive effects on alloreactivity but not on natural immunity in vitroG Pawelec, K Jaschonek, G Ehninger
Immunology Letters|August 1, 1988
Cyclosporin A blocks the generation of alloindifferent but not of allospecific suppressive cellsG Pawelec, I Balko, A Rehbein
Cancer Immunology, Immunotherapy : CII|November 7, 1999
IFN-alpha regulates IL 10 production by CML cells in vitroG Pawelec, E Schlotz, A Rehbein
International Journal of Immunogenetics|July 6, 2011
Immunogenetics of ageingE Naumova, M Ivanova, G Pawelec
Tissue Antigens|April 1, 1986
Gamma ray-induced mutants as a tool for the production and characterisation of monoclonal antibodies against HLA-alloantigensB Spring, G Pawelec, A Ziegler
Oncology Research|January 1, 1992
Tumor-specific antigens revisited: presentation to the immune system of fusion peptides resulting solely from tumor-specific chromosomal translocationsG Pawelec, H Kalbacher, O Bruserud
Pageof 23

Showing results (51-60 of 222) with videos related to

Sort By:
Pageof 23
Cancer Immunology, Immunotherapy : CII|August 4, 1999
Prerequisites for the immunotherapy of cancerG Pawelec, A Engel, M Adibzadeh
Cancer Chemotherapy and Pharmacology|January 1, 1995
In vitro effect of r-verapamil on acute myelogenous leukemia blast cells: studies of cytokine secretion and cytokine-dependent blast proliferationO Bruserud, I Nesthus, G Pawelec
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 5, 2002
Generation of chronic myelogenous leukemia-specific T cells in cytokine-modified autologous mixed lymphocyte/tumor cell culturesL Müller, C Provenzani, G Pawelec
Trends in Immunology|August 9, 2001
MHC class II-restricted tumor antigens and CD4+ T cells play a role in hematological malignancies as well as solid tumorsG Pawelec, L Müller, W Wagner
International Journal of Immunopharmacology|January 1, 1991
The anti-fungal agent itraconazole exerts immunosuppressive effects on alloreactivity but not on natural immunity in vitroG Pawelec, K Jaschonek, G Ehninger
Immunology Letters|August 1, 1988
Cyclosporin A blocks the generation of alloindifferent but not of allospecific suppressive cellsG Pawelec, I Balko, A Rehbein
Cancer Immunology, Immunotherapy : CII|November 7, 1999
IFN-alpha regulates IL 10 production by CML cells in vitroG Pawelec, E Schlotz, A Rehbein
International Journal of Immunogenetics|July 6, 2011
Immunogenetics of ageingE Naumova, M Ivanova, G Pawelec
Tissue Antigens|April 1, 1986
Gamma ray-induced mutants as a tool for the production and characterisation of monoclonal antibodies against HLA-alloantigensB Spring, G Pawelec, A Ziegler
Oncology Research|January 1, 1992
Tumor-specific antigens revisited: presentation to the immune system of fusion peptides resulting solely from tumor-specific chromosomal translocationsG Pawelec, H Kalbacher, O Bruserud
Pageof 23